← Back to Search

Laser Lithotripsy

Holmium laser with thulium lasers for Kidney Stones

Phase 4
Waitlist Available
Led By Stephen Nakada, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 8 weeks (1 month post-operative)
Awards & highlights

Study Summary

This trial will compare the holmium laser with Moses versus the thulium laser in patients undergoing ureteroscopic laser lithotripsy for stone disease.

Eligible Conditions
  • Kidney Stones

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 8 weeks (1 month post-operative)
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 8 weeks (1 month post-operative) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Procedural Time (Minutes)
Secondary outcome measures
Ablation Efficiency (J/mm^3)
Ablation Speed
Change in Quality of Life Survey (WISQOL Short Form) Both Pre-operatively and Post-operatively
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Participants treated with Holmium laser with the thulium laserExperimental Treatment1 Intervention
Group II: Participants treated with Holmium laser with the Moses laserExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Holmium laser with thulium lasers
2021
Completed Phase 4
~120
Holmium laser with Moses lasers
2021
Completed Phase 4
~120

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,176 Previous Clinical Trials
3,011,892 Total Patients Enrolled
4 Trials studying Kidney Stones
3,680 Patients Enrolled for Kidney Stones
Stephen Nakada, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
3 Previous Clinical Trials
257 Total Patients Enrolled
1 Trials studying Kidney Stones
40 Patients Enrolled for Kidney Stones

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the combination of Holmium and Moses lasers been validated by the Federal Drug Administration?

"The safety of holmium laser with Moses lasers is rated at 3 since it has already been sanctioned as part of a Phase 4 trial."

Answered by AI

Who is the ideal candidate for participating in this research?

"This clinical trial seeks 164 participants aged 18 to 89 with kidney stones that require endoscopic treatment in the outpatient operating room. Endorsed applicants must have a single renal unit stone size of 3-10 mm or 11-20 mm, as calculated from preoperative CT scans. Those with multiple stones can still qualify so long as their largest one is within the predetermined range."

Answered by AI

What is the participant size of this clinical experiment?

"Affirmative. Clinicaltrials.gov indicates that the trial, which was initially posted on July 16th 2021, is actively recruiting participants. 164 individuals need to be enrolled from 1 facility."

Answered by AI

Does this trial accept applicants in their golden years?

"The age bracket for enrollment in this clinical trial is between 18 and 89 years old, as specified by the inclusion criteria."

Answered by AI

Is there an ongoing enrollment process for this research project?

"Affirmative. According to the clinicaltrials.gov platform, this trial is actively recruiting individuals who meet its criteria and was first published on July 16th 2021. The current goal is to enroll 164 participants at a single location by August 1st 2022."

Answered by AI
~31 spots leftby Mar 2025